Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    "Focal segmental glomerulosclerosis"
Show Display Options
Rank Status Study
1 Terminated Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: FG-3019
2 Unknown  Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: prednisone, FK506, MMF;   Drug: prednisone
3 Completed
Has Results
Permeability Factor in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Procedure: Plasma exchange;   Drug: Cyclophosphamide
4 Terminated Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: Galactose
5 Recruiting Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)
Condition: Focal Segmental Glomerulosclerosis
Intervention: Biological: Intravenous injection
6 Active, not recruiting Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: RE-021 (Sparsentan);   Drug: Irbesartan
7 Completed Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS
Condition: Focal Segmental Glomerulosclerosis
Intervention: Biological: GC1008
8 Completed Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
Condition: Glomerulosclerosis, Focal
Interventions: Drug: Cyclosporin;   Drug: MMF and Dexamethasone
9 Recruiting Genetic Markers for Focal Segmental Glomerulosclerosis
Conditions: Focal Segmental Glomerulosclerosis;   HIV-Associated Focal Segmental Glomerulosclerosis
Intervention:
10 Completed Rituximab Treatment of Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis (FSGS)
Intervention: Drug: rituximab
11 Recruiting Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Condition: Focal Segmental Glomerulosclerosis 1
Intervention: Device: Liposorber® LA-15 System
12 Completed A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
Condition: Primary Focal Segmental Glomerulosclerosis
Interventions: Drug: fresolimumab;   Drug: Placebo
13 Completed Sirolimus for Focal Segmental Glomerulosclerosis
Condition: Focal Glomerulosclerosis
Intervention: Drug: Sirolimus
14 Completed Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis
Conditions: Proteinuria;   Focal Segmental Glomerulosclerosis
Intervention: Drug: tripterygium wilfordii (TW)
15 Completed A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
Condition: Glomerulosclerosis, Focal Segmental
Intervention: Drug: Losmapimod
16 Completed
Has Results
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: Adalimumab;   Drug: Lisinopril, losartan, and atorvastatin;   Drug: galactose
17 Withdrawn Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5
Condition: Focal Segmental Glomerulosclerosis
Intervention: Drug: Galactose
18 Not yet recruiting Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
Conditions: Kidney Transplantation;   Focal Segmental Glomerulosclerosis (FSGS)
Interventions: Drug: Bleselumab;   Drug: Basiliximab;   Drug: Mycophenolate Mofetil (MMF);   Drug: Tacrolimus Capsules;   Drug: Methylprednisone;   Drug: Prednisone
19 Active, not recruiting A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Condition: Primary Focal Segmental Glomerulosclerosis
Intervention: Biological: Rituximab
20 Recruiting Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis
Conditions: Glomerulosclerosis, Focal Segmental;   Renal Insufficiency, Chronic
Intervention: Biological: Autologous Cell Transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.